English

GREEN VISION BIOTECHNOLOGY CORP.

EDGAR

GVBT Annual report amendment (10-K/A) · filed 2022-09-19

38 filing records in this dataset, filed from 2013-05-03 to 2022-09-19. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2022 Q2 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-17.3 thousand USD

2022 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -25221 USD Source
Operating Cash Flow: -7914 USD Source

Cash and cash equivalents: 17.4 thousand USD 2022-06-30 Source
Exact value

17405 USD
Long-term debt including current maturities: Not available
Shares outstanding: 161 million shares 2022-06-30 Source
Exact value

160790000 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

160790000 shares · 2021-06-30· Source
160790000 shares · 2022-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

410 USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Revenue: 0 USD · 2021-07-01 – 2021-09-30 Source
Revenue: 145099 USD · 2021-01-01 – 2021-12-31 Source
Revenue: 144689 USD · 2021-01-01 – 2021-09-30 Source
Revenue: 0 USD · 2022-01-01 – 2022-03-31 Source
Revenue: 0 USD · 2022-04-01 – 2022-06-30 Source

Operating cash flow

-175 thousand USD

2021-07-01 – 2022-06-30

Exact inputs and evidence

Operating cash flow: -192106 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -85864 USD · 2021-01-01 – 2021-06-30 Source
Operating cash flow: -235309 USD · 2021-01-01 – 2021-12-31 Source
Operating cash flow: -192106 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -7914 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -25221 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -7914 USD · 2022-01-01 – 2022-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-09-19.

Financial data available through: 2021-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2021-12-31
Operating income: 8 of 11 periods available· newest 2021-12-31
Net income: 10 of 11 periods available· newest 2021-12-31
Operating cash flow: 10 of 11 periods available· newest 2021-12-31
Capital expenditure: 4 of 11 periods available· newest 2019-12-31
Total assets: 8 of 11 periods available· newest 2021-12-31
Total liabilities: 8 of 11 periods available· newest 2021-12-31
Current assets: 7 of 11 periods available· newest 2021-12-31
Current liabilities: 8 of 11 periods available· newest 2021-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2021-12-31
long term debt: No compatible figures in this window
Shares outstanding: 8 of 11 periods available· newest 2021-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+67.5%

Prior period

USD 86,650

2020-01-01 – 2020-12-31
Current period

USD 145,099

2021-01-01 – 2021-12-31

Exact inputs and evidence

145099 − 86650 = 58449 USD

86650 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
145099 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · GREEN VISION BIOTECHNOLOGY CORP. · 2021-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Year-over-year change in Revenue: 58449 USD Concept: fundies:Revenue Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 145099 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033422002058/gvbt_10k.htm#391722 Filing: 000164033422002058 Input fundies:Revenue: 86650 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033422002058/gvbt_10k.htm#392251 Filing: 000164033422002058
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 103,750

Prior period

−USD 396,027

2020-01-01 – 2020-12-31
Current period

−USD 499,777

2021-01-01 – 2021-12-31

Exact inputs and evidence

-499777 − -396027 = -103750 USD

-396027 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-499777 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GREEN VISION BIOTECHNOLOGY CORP. · 2021-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Year-over-year change in Net income: -103750 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -499777 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033422002058/gvbt_10k.htm#927529 Filing: 000164033422002058 Input fundies:NetIncome: -396027 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033422002058/gvbt_10k.htm#928058 Filing: 000164033422002058
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 149,704

Prior period

−USD 85,605

2020-01-01 – 2020-12-31
Current period

−USD 235,309

2021-01-01 – 2021-12-31

Exact inputs and evidence

-235309 − -85605 = -149704 USD

-85605 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-235309 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GREEN VISION BIOTECHNOLOGY CORP. · 2021-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Year-over-year change in Operating cash flow: -149704 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -235309 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033422002058/gvbt_10k.htm#538567 Filing: 000164033422002058 Input fundies:OperatingCashFlow: -85605 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033422002058/gvbt_10k.htm#539197 Filing: 000164033422002058
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2021-01-01 – 2021-12-31

Revenue USD 145,099 100% of revenue
Operating costs Derived −USD 376,180 −259% of revenue
Operating income USD 521,279 359% of revenue
Tax, interest and other Derived USD 1.02 million 704% of revenue
Net income −USD 499,777 −344% of revenue

Cash

Operating cash flow −USD 235,309 −162% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2014 Operating loss: operating costs were 337% of revenue.
2015 Not shown: operating income or net income is not reported.
2016 Operating loss: operating costs were 182% of revenue.
2017 Operating loss: operating costs were 1,536% of revenue.
2018 Operating loss: operating costs were 1,163% of revenue.
2019 Operating loss: operating costs were 774% of revenue.
2020 Net loss: net income was −457% of revenue.
2021 Net loss: net income was −344% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2014 2013-02-01 – 2014-01-31	3990	13440 Derived	-9450	0 Derived	-9450	Unavailable	Source 2013-02-01 – 2014-01-31: 3990 USD Inspect Revenue Open source 2013-02-01 – 2014-01-31: -9450 USD Inspect Operating Income Open source 2013-02-01 – 2014-01-31: -9450 USD Inspect Net Income Open source 2013-02-01 – 2014-01-31: -9450 USD Inspect Operating Cash Flow Open source
2015 2014-02-01 – 2015-01-31	0	31154 Derived	-31154	0 Derived	-31154	Unavailable	Source 2014-02-01 – 2015-01-31: 0 USD Inspect Revenue Open source 2014-02-01 – 2015-01-31: -31154 USD Inspect Operating Income Open source 2014-02-01 – 2015-01-31: -31154 USD Inspect Net Income Open source 2014-02-01 – 2015-01-31: -31154 USD Inspect Operating Cash Flow Open source
2016 2016-01-01 – 2016-12-31	1276722	2323392 Derived	-1046670	3227 Derived	-1049897	-363161 Derived	Source 2016-01-01 – 2016-12-31: 1276722 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -1046670 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -1049897 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -356612 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 6549 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	135126	2075924 Derived	-1940798	-257628 Derived	-1683170	Unavailable	Source 2017-01-01 – 2017-12-31: 135126 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -1940798 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -1683170 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -279609 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: -1936 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	99595	1158363 Derived	-1058768	303354 Derived	-1362122	-315178 Derived	Source 2018-01-01 – 2018-12-31: 99595 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -1058768 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -1362122 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -314565 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 613 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	79950	618437 Derived	-538487	-41797 Derived	-496690	153631 Derived	Source 2019-01-01 – 2019-12-31: 79950 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -538487 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -496690 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 153631 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 0 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	86650	-438101 Derived	524751	920778 Derived	-396027	Unavailable	Source 2020-01-01 – 2020-12-31: 86650 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 524751 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -396027 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -85605 USD Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	145099	-376180 Derived	521279	1021056 Derived	-499777	Unavailable	Source 2021-01-01 – 2021-12-31: 145099 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 521279 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -499777 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -235309 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 145.1K 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-01-31	Revenue	3990	Revenue: 3990 Open source
20152015-01-31	Revenue	0	Revenue: 0 Open source
20162016-12-31	Revenue	1276722	Revenue: 1276722 Open source
20172017-12-31	Revenue	135126	Revenue: 135126 Open source
20182018-12-31	Revenue	99595	Revenue: 99595 Open source
20192019-12-31	Revenue	79950	Revenue: 79950 Open source
20202020-12-31	Revenue	86650	Revenue: 86650 Open source
20212021-12-31	Revenue	145099	Revenue: 145099 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

67.5% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20142014-01-31	Year over year	No prior comparable period	Revenue: 3990 Open source
20152015-01-31	Year over year	-100%	Revenue: 0 Open source Revenue: 3990 Open source
20162016-12-31	Year over year	No prior comparable period	Revenue: 1276722 Open source
20172017-12-31	Year over year	-89.4%	Revenue: 135126 Open source Revenue: 1276722 Open source
20182018-12-31	Year over year	-26.3%	Revenue: 99595 Open source Revenue: 135126 Open source
20192019-12-31	Year over year	-19.7%	Revenue: 79950 Open source Revenue: 99595 Open source
20202020-12-31	Year over year	8.4%	Revenue: 86650 Open source Revenue: 79950 Open source
20212021-12-31	Year over year	67.5%	Revenue: 145099 Open source Revenue: 86650 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 359.3% 2021

Net margin -344.4% 2021

Free cash flow margin 192.2% 2019

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20142014-01-31	Operating margin	-236.8%	Operating Income: -9450 Open source Revenue: 3990 Open source
20152015-01-31	Operating margin	Not reported	Operating Income: -31154 Open source Revenue: 0 Open source
20162016-12-31	Operating margin	-82%	Operating Income: -1046670 Open source Revenue: 1276722 Open source
20172017-12-31	Operating margin	-1,436.3%	Operating Income: -1940798 Open source Revenue: 135126 Open source
20182018-12-31	Operating margin	-1,063.1%	Operating Income: -1058768 Open source Revenue: 99595 Open source
20192019-12-31	Operating margin	-673.5%	Operating Income: -538487 Open source Revenue: 79950 Open source
20202020-12-31	Operating margin	605.6%	Operating Income: 524751 Open source Revenue: 86650 Open source
20212021-12-31	Operating margin	359.3%	Operating Income: 521279 Open source Revenue: 145099 Open source
20142014-01-31	Net margin	-236.8%	Net Income: -9450 Open source Revenue: 3990 Open source
20152015-01-31	Net margin	Not reported	Net Income: -31154 Open source Revenue: 0 Open source
20162016-12-31	Net margin	-82.2%	Net Income: -1049897 Open source Revenue: 1276722 Open source
20172017-12-31	Net margin	-1,245.6%	Net Income: -1683170 Open source Revenue: 135126 Open source
20182018-12-31	Net margin	-1,367.7%	Net Income: -1362122 Open source Revenue: 99595 Open source
20192019-12-31	Net margin	-621.3%	Net Income: -496690 Open source Revenue: 79950 Open source
20202020-12-31	Net margin	-457%	Net Income: -396027 Open source Revenue: 86650 Open source
20212021-12-31	Net margin	-344.4%	Net Income: -499777 Open source Revenue: 145099 Open source
20142014-01-31	Free cash flow margin	Not reported	Revenue: 3990 Open source Operating Cash Flow: -9450 Open source
20152015-01-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -31154 Open source
20162016-12-31	Free cash flow margin	-28.4%	Revenue: 1276722 Open source Operating Cash Flow: -356612 Open source Capital Expenditure: 6549 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 135126 Open source Operating Cash Flow: -279609 Open source Capital Expenditure: -1936 Open source
20182018-12-31	Free cash flow margin	-316.5%	Revenue: 99595 Open source Operating Cash Flow: -314565 Open source Capital Expenditure: 613 Open source
20192019-12-31	Free cash flow margin	192.2%	Revenue: 79950 Open source Operating Cash Flow: 153631 Open source Capital Expenditure: 0 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 86650 Open source Operating Cash Flow: -85605 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 145099 Open source Operating Cash Flow: -235309 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -235.3K 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-01-31	Operating cash flow	-9450	Operating Cash Flow: -9450 Open source
20152015-01-31	Operating cash flow	-31154	Operating Cash Flow: -31154 Open source
20162016-12-31	Operating cash flow	-356612	Operating Cash Flow: -356612 Open source
20172017-12-31	Operating cash flow	-279609	Operating Cash Flow: -279609 Open source
20182018-12-31	Operating cash flow	-314565	Operating Cash Flow: -314565 Open source
20192019-12-31	Operating cash flow	153631	Operating Cash Flow: 153631 Open source
20202020-12-31	Operating cash flow	-85605	Operating Cash Flow: -85605 Open source
20212021-12-31	Operating cash flow	-235309	Operating Cash Flow: -235309 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 153.6K 2019

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-01-31	Free cash flow	Unavailable	Operating Cash Flow: -9450 Open source
20152015-01-31	Free cash flow	Unavailable	Operating Cash Flow: -31154 Open source
20162016-12-31	Free cash flow	-363161	Operating Cash Flow: -356612 Open source Capital Expenditure: 6549 Open source
20172017-12-31	Free cash flow	Unavailable	Operating Cash Flow: -279609 Open source Capital Expenditure: -1936 Open source
20182018-12-31	Free cash flow	-315178	Operating Cash Flow: -314565 Open source Capital Expenditure: 613 Open source
20192019-12-31	Free cash flow	153631	Operating Cash Flow: 153631 Open source Capital Expenditure: 0 Open source
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -85605 Open source
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -235309 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

370.9% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20142014-01-31	Liabilities / assets	28.4%	Total Liabilities: 5678 Open source Total Assets: 20009 Open source
20152015-01-31	Liabilities / assets	9,713.1%	Total Liabilities: 16998 Open source Total Assets: 175 Open source
20162016-12-31	Liabilities / assets	144.3%	Total Liabilities: 10849730 Open source Total Assets: 7518562 Open source
20172017-12-31	Liabilities / assets	216.7%	Total Liabilities: 9457164 Open source Total Assets: 4365092 Open source
20182018-12-31	Liabilities / assets	298.4%	Total Liabilities: 9633564 Open source Total Assets: 3228466 Open source
20192019-12-31	Liabilities / assets	326.3%	Total Liabilities: 9969660 Open source Total Assets: 3055137 Open source
20202020-12-31	Liabilities / assets	344.2%	Total Liabilities: 10450911 Open source Total Assets: 3036370 Open source
20212021-12-31	Liabilities / assets	370.9%	Total Liabilities: 10838657 Open source Total Assets: 2922168 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2014-01-31	Current assets / current liabilities	Not reported	Current Liabilities: 5678 Open source
20152015-01-31	Current assets / current liabilities	0.01×	Current Assets: 175 Open source Current Liabilities: 16998 Open source
20162016-12-31	Current assets / current liabilities	0.32×	Current Assets: 3516127 Open source Current Liabilities: 10849730 Open source
20172017-12-31	Current assets / current liabilities	0.05×	Current Assets: 428119 Open source Current Liabilities: 9457164 Open source
20182018-12-31	Current assets / current liabilities	0×	Current Assets: 36650 Open source Current Liabilities: 9633564 Open source
20192019-12-31	Current assets / current liabilities	0.01×	Current Assets: 98957 Open source Current Liabilities: 9969660 Open source
20202020-12-31	Current assets / current liabilities	0×	Current Assets: 50920 Open source Current Liabilities: 10450911 Open source
20212021-12-31	Current assets / current liabilities	0×	Current Assets: 29782 Open source Current Liabilities: 10838657 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2014 2013-02-01 – 2014-01-31	−USD 9,450 Exact value Exact value: -9450 USD 2013-02-01 – 2014-01-31: -9450 USD Inspect Net Income Open source Share or cite Citation for Net Income · GREEN VISION BIOTECHNOLOGY CORP. · 2014-01-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Net Income: -9450 USD Concept: fundies:NetIncome Period: 2013-02-01 to 2014-01-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3ANetIncome&period=2014-01-31&surface=latest&period_type=duration&start=2013-02-01&unit=USD&dimensions= Input fundies:NetIncome: -9450 USD (2013-02-01 to 2014-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000157180415000006/antr-20150131.xml#5617 Filing: 000157180415000006 The citation records this snapshot. The page link may show a newer release later.	−USD 9,450 Exact value Exact value: -9450 USD 2013-02-01 – 2014-01-31: -9450 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GREEN VISION BIOTECHNOLOGY CORP. · 2014-01-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Operating Cash Flow: -9450 USD Concept: fundies:OperatingCashFlow Period: 2013-02-01 to 2014-01-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3AOperatingCashFlow&period=2014-01-31&surface=latest&period_type=duration&start=2013-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9450 USD (2013-02-01 to 2014-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000157180415000006/antr-20150131.xml#6797 Filing: 000157180415000006 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2014-02-01 – 2015-01-31	−USD 31,154 Exact value Exact value: -31154 USD 2014-02-01 – 2015-01-31: -31154 USD Inspect Net Income Open source Share or cite Citation for Net Income · GREEN VISION BIOTECHNOLOGY CORP. · 2015-01-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Net Income: -31154 USD Concept: fundies:NetIncome Period: 2014-02-01 to 2015-01-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3ANetIncome&period=2015-01-31&surface=latest&period_type=duration&start=2014-02-01&unit=USD&dimensions= Input fundies:NetIncome: -31154 USD (2014-02-01 to 2015-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033416001112/vibx-20160131.xml#23881 Filing: 000164033416001112 The citation records this snapshot. The page link may show a newer release later.	−USD 31,154 Exact value Exact value: -31154 USD 2014-02-01 – 2015-01-31: -31154 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GREEN VISION BIOTECHNOLOGY CORP. · 2015-01-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Operating Cash Flow: -31154 USD Concept: fundies:OperatingCashFlow Period: 2014-02-01 to 2015-01-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3AOperatingCashFlow&period=2015-01-31&surface=latest&period_type=duration&start=2014-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31154 USD (2014-02-01 to 2015-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033416001112/vibx-20160131.xml#25646 Filing: 000164033416001112 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2015-02-01 – 2016-01-31	−USD 37,560 Exact value Exact value: -37560 USD 2015-02-01 – 2016-01-31: -37560 USD Inspect Net Income Open source Share or cite Citation for Net Income · GREEN VISION BIOTECHNOLOGY CORP. · 2016-01-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Net Income: -37560 USD Concept: fundies:NetIncome Period: 2015-02-01 to 2016-01-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3ANetIncome&period=2016-01-31&surface=latest&period_type=duration&start=2015-02-01&unit=USD&dimensions= Input fundies:NetIncome: -37560 USD (2015-02-01 to 2016-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033417000808/gvbt-20170131.xml#22532 Filing: 000164033417000808 The citation records this snapshot. The page link may show a newer release later.	−USD 35,289 Exact value Exact value: -35289 USD 2015-02-01 – 2016-01-31: -35289 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GREEN VISION BIOTECHNOLOGY CORP. · 2016-01-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Operating Cash Flow: -35289 USD Concept: fundies:OperatingCashFlow Period: 2015-02-01 to 2016-01-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3AOperatingCashFlow&period=2016-01-31&surface=latest&period_type=duration&start=2015-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35289 USD (2015-02-01 to 2016-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033417000808/gvbt-20170131.xml#25284 Filing: 000164033417000808 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	−USD 1.05 million Exact value Exact value: -1049897 USD 2016-01-01 – 2016-12-31: -1049897 USD Inspect Net Income Open source Share or cite Citation for Net Income · GREEN VISION BIOTECHNOLOGY CORP. · 2016-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Net Income: -1049897 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1049897 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033418000746/gvbt-20171231.xml#96810 Filing: 000164033418000746 The citation records this snapshot. The page link may show a newer release later.	−USD 356,612 Exact value Exact value: -356612 USD 2016-01-01 – 2016-12-31: -356612 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GREEN VISION BIOTECHNOLOGY CORP. · 2016-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Operating Cash Flow: -356612 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -356612 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033418000746/gvbt-20171231.xml#186150 Filing: 000164033418000746 The citation records this snapshot. The page link may show a newer release later.	USD 6,549 Exact value Exact value: 6549 USD 2016-01-01 – 2016-12-31: 6549 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GREEN VISION BIOTECHNOLOGY CORP. · 2016-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Capital Expenditure: 6549 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6549 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033418000746/gvbt-20171231.xml#186585 Filing: 000164033418000746 The citation records this snapshot. The page link may show a newer release later.	−USD 363,161 Calculation and evidence -356612 − 6549 USD Exact free cash flow: -363161 USD 2016-01-01 – 2016-12-31: -356612 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 6549 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GREEN VISION BIOTECHNOLOGY CORP. · 2016-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Free cash flow: -363161 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -356612 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033418000746/gvbt-20171231.xml#186150 Filing: 000164033418000746 Input fundies:CapitalExpenditure: 6549 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033418000746/gvbt-20171231.xml#186585 Filing: 000164033418000746 The citation records this snapshot. The page link may show a newer release later.
2017 2016-02-01 – 2017-01-31	−USD 69,613 Exact value Exact value: -69613 USD 2016-02-01 – 2017-01-31: -69613 USD Inspect Net Income Open source Share or cite Citation for Net Income · GREEN VISION BIOTECHNOLOGY CORP. · 2017-01-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Net Income: -69613 USD Concept: fundies:NetIncome Period: 2016-02-01 to 2017-01-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3ANetIncome&period=2017-01-31&surface=latest&period_type=duration&start=2016-02-01&unit=USD&dimensions= Input fundies:NetIncome: -69613 USD (2016-02-01 to 2017-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033417000808/gvbt-20170131.xml#23243 Filing: 000164033417000808 The citation records this snapshot. The page link may show a newer release later.	−USD 64,940 Exact value Exact value: -64940 USD 2016-02-01 – 2017-01-31: -64940 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GREEN VISION BIOTECHNOLOGY CORP. · 2017-01-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Operating Cash Flow: -64940 USD Concept: fundies:OperatingCashFlow Period: 2016-02-01 to 2017-01-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3AOperatingCashFlow&period=2017-01-31&surface=latest&period_type=duration&start=2016-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -64940 USD (2016-02-01 to 2017-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033417000808/gvbt-20170131.xml#25533 Filing: 000164033417000808 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 1.68 million Exact value Exact value: -1683170 USD 2017-01-01 – 2017-12-31: -1683170 USD Inspect Net Income Open source Share or cite Citation for Net Income · GREEN VISION BIOTECHNOLOGY CORP. · 2017-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Net Income: -1683170 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1683170 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033420001240/gvbt-20181231.xml#75839 Filing: 000164033420001240 The citation records this snapshot. The page link may show a newer release later.	−USD 279,609 Exact value Exact value: -279609 USD 2017-01-01 – 2017-12-31: -279609 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GREEN VISION BIOTECHNOLOGY CORP. · 2017-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Operating Cash Flow: -279609 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -279609 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033420001240/gvbt-20181231.xml#91436 Filing: 000164033420001240 The citation records this snapshot. The page link may show a newer release later.	Unavailable The mapped spending value is negative, so its direction is unclear. Source Inspect Capital Expenditure Open source	Unavailable Capital expenditure has a negative mapped value; spending direction is unclear.
2018 2018-01-01 – 2018-12-31	−USD 1.36 million Exact value Exact value: -1362122 USD 2018-01-01 – 2018-12-31: -1362122 USD Inspect Net Income Open source Share or cite Citation for Net Income · GREEN VISION BIOTECHNOLOGY CORP. · 2018-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Net Income: -1362122 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1362122 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033421000040/gvbt-20191231.xml#78164 Filing: 000164033421000040 The citation records this snapshot. The page link may show a newer release later.	−USD 314,565 Exact value Exact value: -314565 USD 2018-01-01 – 2018-12-31: -314565 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GREEN VISION BIOTECHNOLOGY CORP. · 2018-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Operating Cash Flow: -314565 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -314565 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033421000040/gvbt-20191231.xml#93641 Filing: 000164033421000040 The citation records this snapshot. The page link may show a newer release later.	USD 613 Exact value Exact value: 613 USD 2018-01-01 – 2018-12-31: 613 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GREEN VISION BIOTECHNOLOGY CORP. · 2018-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Capital Expenditure: 613 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 613 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033421000040/gvbt-20191231.xml#93999 Filing: 000164033421000040 The citation records this snapshot. The page link may show a newer release later.	−USD 315,178 Calculation and evidence -314565 − 613 USD Exact free cash flow: -315178 USD 2018-01-01 – 2018-12-31: -314565 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 613 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GREEN VISION BIOTECHNOLOGY CORP. · 2018-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Free cash flow: -315178 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -314565 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033421000040/gvbt-20191231.xml#93641 Filing: 000164033421000040 Input fundies:CapitalExpenditure: 613 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033421000040/gvbt-20191231.xml#93999 Filing: 000164033421000040 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 496,690 Exact value Exact value: -496690 USD 2019-01-01 – 2019-12-31: -496690 USD Inspect Net Income Open source Share or cite Citation for Net Income · GREEN VISION BIOTECHNOLOGY CORP. · 2019-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Net Income: -496690 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -496690 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033421002258/gvbt_10q.htm#912795 Filing: 000164033421002258 The citation records this snapshot. The page link may show a newer release later.	USD 153,631 Exact value Exact value: 153631 USD 2019-01-01 – 2019-12-31: 153631 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GREEN VISION BIOTECHNOLOGY CORP. · 2019-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Operating Cash Flow: 153631 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 153631 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033421002258/gvbt_10q.htm#562546 Filing: 000164033421002258 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2019-01-01 – 2019-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GREEN VISION BIOTECHNOLOGY CORP. · 2019-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033421000040/gvbt-20191231.xml#93823 Filing: 000164033421000040 The citation records this snapshot. The page link may show a newer release later.	USD 153,631 Calculation and evidence 153631 − 0 USD Exact free cash flow: 153631 USD 2019-01-01 – 2019-12-31: 153631 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GREEN VISION BIOTECHNOLOGY CORP. · 2019-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Free cash flow: 153631 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 153631 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033421002258/gvbt_10q.htm#562546 Filing: 000164033421002258 Input fundies:CapitalExpenditure: 0 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033421000040/gvbt-20191231.xml#93823 Filing: 000164033421000040 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 396,027 Exact value Exact value: -396027 USD 2020-01-01 – 2020-12-31: -396027 USD Inspect Net Income Open source Share or cite Citation for Net Income · GREEN VISION BIOTECHNOLOGY CORP. · 2020-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Net Income: -396027 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -396027 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033422002058/gvbt_10k.htm#928058 Filing: 000164033422002058 The citation records this snapshot. The page link may show a newer release later.	−USD 85,605 Exact value Exact value: -85605 USD 2020-01-01 – 2020-12-31: -85605 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GREEN VISION BIOTECHNOLOGY CORP. · 2020-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Operating Cash Flow: -85605 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -85605 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033422002058/gvbt_10k.htm#539197 Filing: 000164033422002058 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 499,777 Exact value Exact value: -499777 USD 2021-01-01 – 2021-12-31: -499777 USD Inspect Net Income Open source Share or cite Citation for Net Income · GREEN VISION BIOTECHNOLOGY CORP. · 2021-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Net Income: -499777 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -499777 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033422002058/gvbt_10k.htm#927529 Filing: 000164033422002058 The citation records this snapshot. The page link may show a newer release later.	−USD 235,309 Exact value Exact value: -235309 USD 2021-01-01 – 2021-12-31: -235309 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GREEN VISION BIOTECHNOLOGY CORP. · 2021-12-31 GREEN VISION BIOTECHNOLOGY CORP. (edgar:1571804) Operating Cash Flow: -235309 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:14:41Z Snapshot: 3bc84d46dc924d83216b56ecc732a1ddeff5737085046a07b53297302179d7bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1571804/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -235309 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1571804/000164033422002058/gvbt_10k.htm#538567 Filing: 000164033422002058 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

38 filings · 2,088 latest values · 2,088 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001571804, 1571804, GVBT, antr, aynt, edgar:1571804, gvbt, vibx

Also known as ANYTRANSLATION CORP, Anytranslation Corp, GREEN VISION BIOTECHNOLOGY CORP, GREEN VISION BIOTECHNOLOGY CORP., VIBE WIRELESS CORP.

GREEN VISION BIOTECHNOLOGY CORP.

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2021 2021-01-01 – 2021-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation